Pharmacy Technician’s Letter | CE Made Simple & License Tracking

May 2026 Issue

Watch for the New Oral GLP-1 Agonist Orforglipron

New Rx orforglipron (Foundayo) is the second ORAL GLP-1 receptor agonist approved for adults with overweight or obesity...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Comparison of Weight Loss Products
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More

Estrogen Patch Shortages: How to Help

High demand and shortages are leading to questions about estrogen patches for menopausal hormone therapy (MHT)...

Listen for Patient Questions About Gabapentin

Patients are asking more questions about gabapentin based on claims from social media, family and friends, etc...

Help Offer Strategies to Improve Medication Taste

You’re in a prime spot to help make icky meds taste better...

GO TO FULL ISSUE

CE & Training

FEATURED SELF-STUDY CE: 2026 Immunization Updates

CE-IN-THE-LETTER: Pharmacy Technician's Letter May 2026

LIVE CE: Pharmacy Essential Updates May 2026

PODCAST CE: Clinical Capsules - Semaglutide Becomes the First ORAL GLP-1 Approved for Weight Loss

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Quantity & Days' Supply Calculations: unlimited math quizzes!

Group Purchases & Pricing

Pharmacy Technician’s Letter is eligible for bulk discounts. Ensure staff meet license renewal requirements. Easily manage training. Bundle with other products for significant savings. Request information